1.

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Onc...

2.

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Onc...

3.

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Onc...

1.

Nationwide population-based cohort study of uterine rupture in Belgium: Results from the Belgian obstetric surveillance system

2.

Nationwide population-based cohort study of uterine rupture in Belgium: Results from the Belgian obstetric surveillance system

3.

Nationwide population-based cohort study of uterine rupture in Belgium: Results from the Belgian obstetric surveillance system

4.

Nationwide population-based cohort study of uterine rupture in Belgium: Results from the Belgian obstetric surveillance system

5.

Nationwide population-based cohort study of uterine rupture in Belgium: Results from the Belgian obstetric surveillance system

1.

Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies.

2.

Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies.

3.

Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies.

1.

Decisional conflict of physicians during the decision-making process for a simulated advanced-stage cancer patient: an international longitudinal study with German and Belgian phys...

2.

Decisional conflict of physicians during the decision-making process for a simulated advanced-stage cancer patient: an international longitudinal study with German and Belgian phys...

3.

Decisional conflict of physicians during the decision-making process for a simulated advanced-stage cancer patient: an international longitudinal study with German and Belgian phys...

1.

Evaluation of the Belgian Guidelines Website EBMPracticeNet in French General Practice.

2.

Evaluation of the Belgian Guidelines Website EBMPracticeNet in French General Practice.

3.

Evaluation of the Belgian Guidelines Website EBMPracticeNet in French General Practice.

1.

Immunogenicity of COVID-19 Vaccination in Patients With Axial Spondyloarthritis: A Monocentric Prospective Belgian Cohort Study.

2.

Immunogenicity of COVID-19 Vaccination in Patients With Axial Spondyloarthritis: A Monocentric Prospective Belgian Cohort Study.

3.

Immunogenicity of COVID-19 Vaccination in Patients With Axial Spondyloarthritis: A Monocentric Prospective Belgian Cohort Study.

1.

Appropriateness of Non-vitamin K Antagonist Oral Anticoagulants Dosing According to Different Prescription Guides Used in Belgian Ambulatory Care

2.

Appropriateness of Non-vitamin K Antagonist Oral Anticoagulants Dosing According to Different Prescription Guides Used in Belgian Ambulatory Care

3.

Appropriateness of Non-vitamin K Antagonist Oral Anticoagulants Dosing According to Different Prescription Guides Used in Belgian Ambulatory Care

1.

Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.

2.

Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.

3.

Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.

1.

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry : clues for the optimization of rituximab treatment strategies.

2.

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry : clues for the optimization of rituximab treatment strategies.

3.

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry : clues for the optimization of rituximab treatment strategies.

4.

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry : clues for the optimization of rituximab treatment strategies.

5.

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry : clues for the optimization of rituximab treatment strategies.

6.

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry : clues for the optimization of rituximab treatment strategies.

7.

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry : clues for the optimization of rituximab treatment strategies.

8.

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry : clues for the optimization of rituximab treatment strategies.

1.

Prolonged cough in children: a summary of the Belgian primary care clinical guideline.

2.

Prolonged cough in children: a summary of the Belgian primary care clinical guideline.

3.

Prolonged cough in children: a summary of the Belgian primary care clinical guideline.

4.

Prolonged cough in children: a summary of the Belgian primary care clinical guideline.

5.

Prolonged cough in children: a summary of the Belgian primary care clinical guideline.

6.

Prolonged cough in children: a summary of the Belgian primary care clinical guideline.

7.

Prolonged cough in children: a summary of the Belgian primary care clinical guideline.

8.

Prolonged cough in children: a summary of the Belgian primary care clinical guideline.

1.

Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian Univers...

2.

Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian Univers...

3.

Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian Univers...

4.

Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian Univers...

5.

Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian Univers...

6.

Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian Univers...

7.

Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian Univers...

8.

Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian Univers...

1.

Fewer pre-emptive renal transplantations and more rejections in immigrant children compared to native Dutch and Belgian children.

2.

Fewer pre-emptive renal transplantations and more rejections in immigrant children compared to native Dutch and Belgian children.

3.

Fewer pre-emptive renal transplantations and more rejections in immigrant children compared to native Dutch and Belgian children.

4.

Fewer pre-emptive renal transplantations and more rejections in immigrant children compared to native Dutch and Belgian children.

5.

Fewer pre-emptive renal transplantations and more rejections in immigrant children compared to native Dutch and Belgian children.

6.

Fewer pre-emptive renal transplantations and more rejections in immigrant children compared to native Dutch and Belgian children.

7.

Fewer pre-emptive renal transplantations and more rejections in immigrant children compared to native Dutch and Belgian children.

8.

Fewer pre-emptive renal transplantations and more rejections in immigrant children compared to native Dutch and Belgian children.

9.

Fewer pre-emptive renal transplantations and more rejections in immigrant children compared to native Dutch and Belgian children.

1.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

2.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

3.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

4.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

5.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

6.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

7.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

8.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

9.

Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents.

1.

Perceived work ability and turnover intentions: a prospective study among Belgian healthcare workers

2.

Perceived work ability and turnover intentions: a prospective study among Belgian healthcare workers

3.

Perceived work ability and turnover intentions: a prospective study among Belgian healthcare workers

4.

Perceived work ability and turnover intentions: a prospective study among Belgian healthcare workers

5.

Perceived work ability and turnover intentions: a prospective study among Belgian healthcare workers

6.

Perceived work ability and turnover intentions: a prospective study among Belgian healthcare workers

7.

Perceived work ability and turnover intentions: a prospective study among Belgian healthcare workers

8.

Perceived work ability and turnover intentions: a prospective study among Belgian healthcare workers

1.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

2.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

3.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

4.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

5.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

6.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

7.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

8.

Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

1.

Urban Tropospheric Ozone Increases the Prevalence of Vitamin D Deficiency among Belgian Postmenopausal Women with Outdoor Activities during Summer.

2.

Urban Tropospheric Ozone Increases the Prevalence of Vitamin D Deficiency among Belgian Postmenopausal Women with Outdoor Activities during Summer.

3.

Urban Tropospheric Ozone Increases the Prevalence of Vitamin D Deficiency among Belgian Postmenopausal Women with Outdoor Activities during Summer.

4.

Urban Tropospheric Ozone Increases the Prevalence of Vitamin D Deficiency among Belgian Postmenopausal Women with Outdoor Activities during Summer.

5.

Urban Tropospheric Ozone Increases the Prevalence of Vitamin D Deficiency among Belgian Postmenopausal Women with Outdoor Activities during Summer.

6.

Urban Tropospheric Ozone Increases the Prevalence of Vitamin D Deficiency among Belgian Postmenopausal Women with Outdoor Activities during Summer.

7.

Urban Tropospheric Ozone Increases the Prevalence of Vitamin D Deficiency among Belgian Postmenopausal Women with Outdoor Activities during Summer.

8.

Urban Tropospheric Ozone Increases the Prevalence of Vitamin D Deficiency among Belgian Postmenopausal Women with Outdoor Activities during Summer.

1.

Malocclusion, dental injuries and dental anomalies in the primary dentition of Belgian children.

2.

Malocclusion, dental injuries and dental anomalies in the primary dentition of Belgian children.

3.

Malocclusion, dental injuries and dental anomalies in the primary dentition of Belgian children.

4.

Malocclusion, dental injuries and dental anomalies in the primary dentition of Belgian children.

5.

Malocclusion, dental injuries and dental anomalies in the primary dentition of Belgian children.

6.

Malocclusion, dental injuries and dental anomalies in the primary dentition of Belgian children.

7.

Malocclusion, dental injuries and dental anomalies in the primary dentition of Belgian children.

8.

Malocclusion, dental injuries and dental anomalies in the primary dentition of Belgian children.

1.

Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumat...

2.

Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumat...

3.

Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumat...

4.

Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumat...

5.

Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumat...

6.

Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumat...

7.

Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumat...

8.

Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumat...

1.

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

2.

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

3.

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

4.

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

5.

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

6.

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

7.

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

8.

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort

1.

Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017.

2.

Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017.

3.

Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017.

4.

Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017.

5.

Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017.

6.

Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017.

7.

Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017.

8.

Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017.